CD19-BCMA Dual Nanobody Based CAR-T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19-BCMA Dual Nanobody Based CAR-T Cells, covering 2026-03-06 to 2026-03-06. Get the full timeline:
Most recent: Clinical Trial Update: CD19-BCMA Dual Nanobody Based CAR-T Cells for Patients With DSA [Phase 1, Phase 2]